SCHEMBL21362717

SCHEMBL21362717

O=C(c1ccc(P)cc1)c1cc(CBr)ccc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
RXRA P19793 1/20 0.35
MAPT P10636 4/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ACHE P22303 1/20 0.34
KCNH2 Q12809 3/20 0.34
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
CFD P00746 1/20 0.33
MEP1B Q16820 1/20 0.33
AKR1C3 P42330 1/20 0.33
PTPN1 P18031 1/20 0.33
PPARG P37231 1/20 0.32
RAB9A P51151 1/20 0.32
NPC1 O15118 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157898 0.84 PTPN1 (0.43) CES2CES1CYP4F2CYP4A11MAPT
SCHEMBL20157429 0.84 SRD5A2 (0.49) CYP4F2CYP4A11RXRAMAPTHTT
SCHEMBL7514179 0.74 PTPN1 (0.47) CES2CES1CYP4F2CYP4A11CFD
SCHEMBL18680481 0.73 CYP4F2 (0.45) CES2CES1CYP4F2CYP4A11MAPT
SCHEMBL603667 0.72 ALDH1A1 (0.50) CYP4F2CYP4A11MAPTHTTSMN1; SMN2
SCHEMBL20157297 0.72 GSK3B (0.43) CES2CES1CYP4F2CYP4A11MAPT
SCHEMBL20157960 0.72 SRD5A2 (0.49) CES2CES1CYP4F2CYP4A11RXRA
SCHEMBL20157560 0.72 PTPN1 (0.43) CES2CES1MAPTHTTSMN1; SMN2
SCHEMBL21362731 0.71 NPC1 (0.38) RXRAMAPTHTTSMN1; SMN2HDAC6
SCHEMBL7266114 0.70 CYP4F2 (0.54) CYP4F2CYP4A11MAPTPPARGRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed